XNAS: ALLO
Allogene Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf"...
Read More
1.69
-0.04
(-2.31%)
12.7M
XNAS Volume
High volume today
XNAS 18 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Allogene Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..